Small caps

Zelda Therapeutics banks $982,000 R&D cash ahead of Ilera Therapeutics...

The tax refund will be used on the cannabinoid-based therapeutics developer’s program as it...

1 day, 7 hours ago
Buds n Duds

Buds & Duds: Cannabis stocks on upswing; CB2 Insights, KushCo report strong...

Cannabis analytics company CB2 Insights posted record third-quarter revenue of C$4.2 million, a...

3 days, 14 hours ago


Buds & Duds: Cannabis stocks off to rocky start ahead of much-anticipated...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, slipped 1.7% at 130.3 points. Elsewhere, the OTCQX Cannabis Index lost 0.4% at 469.8 points. Buds today were Aleafia Health Inc (TSE:ALEF) (OTCMKTS:ALEAF), CB2 Insights Inc (CSE:CBII)...

12 hours, 19 minutes ago

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Mirasol Resources Ltd. -
Mirasol Resources' business model built on discovery and partnerships

Mirasol also bills itself as a project generator in which attracting quality partners on...

16 hours, 40 minutes ago
Deep dive

Redfund Capital Corp budding into a top-tier cannabis financier, incubator...

The cannabis-focused merchant bank has a blueprint to build a portfolio of 20 companies with $75...

17 hours, 40 minutes ago
Deep dive

Acasti Pharma edging closer to commercializing CaPre as it eyes topline...

High levels of triglycerides in the blood are known to contribute to heart disease

4 days, 18 hours ago
Deep dive

1933 Industries is tapping into the US cannabis market's potential as a new...

The cannabis company is progressing with plans to launch one of Nevada's largest hemp extraction...

1 week, 1 day ago
Deep dive

Matinas BioPharma advances the promise of omega-3 fatty acids

The New Jersey-based company's lead product candidate is MAT9001 for the treatment of...

1 week, 4 days ago

Proactive news

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.